Clinical Glycomics Employing Graphitized Carbon Liquid Chromatography–Mass Spectrometry
Open Access
- 9 December 2014
- journal article
- review article
- Published by Springer Nature in Chromatographia
- Vol. 78 (5-6) , 307-320
Abstract
Glycoconjugates and free glycan are involved in a variety of biological processes such as cell–cell interaction and cell trafficking. Alterations in the complex glycosylation machinery have been correlated with various pathological processes including cancer progression and metastasis. Mass Spectrometry (MS) has evolved as one of the most powerful tools in glycomics and glycoproteomics and in combination with porous graphitized carbon–liquid chromatography (PGC–LC) it is a versatile and sensitive technique for the analysis of glycans and to some extent also glycopeptides. PGC–LC–ESI–MS analysis is characterized by a high isomer separation power enabling a specific glycan compound analysis on the level of individual structures. This allows the investigation of the biological relevance of particular glycan structures and glycan features. Consequently, this strategy is a very powerful technique suitable for clinical research, such as cancer biomarker discovery, as well as in-depth analysis of recombinant glycoproteins. In this review, we will focus on how PGC in conjunction with MS detection can deliver specific structural information for clinical research on protein-bound N-glycans and mucin-type O-glycans. In addition, we will briefly review PGC analysis approaches for glycopeptides, glycosaminoglycans (GAGs) and human milk oligosaccharides (HMOs). The presented applications cover systems that vary vastly with regard to complexity such as purified glycoproteins, cells, tissue or body fluids revealing specific glycosylation changes associated with various biological processes including cancer and inflammation.Keywords
This publication has 138 references indexed in Scilit:
- The glycolyzer: Automated glycan annotation software for high performance mass spectrometry and its application to ovarian cancer glycan biomarker discoveryProteomics, 2012
- Annotation of a Serum N-Glycan Library for Rapid Identification of StructuresJournal of Proteome Research, 2012
- Identification of Glycan Structure Alterations on Cell Membrane Proteins in Desoxyepothilone B Resistant Leukemia CellsMolecular & Cellular Proteomics, 2011
- Comprehensive native glycan profiling with isomer separation and quantitation for the discovery of cancer biomarkersThe Analyst, 2011
- A Comprehensive Compositional Analysis of Heparin/Heparan Sulfate-Derived Disaccharides from Human SerumAnalytical Chemistry, 2011
- Mucin dynamics and enteric pathogensNature Reviews Microbiology, 2011
- Glycan labeling strategies and their use in identification and quantificationAnalytical and Bioanalytical Chemistry, 2010
- Profile of native N‐linked glycan structures from human serum using high performance liquid chromatography on a microfluidic chip and time‐of‐flight mass spectrometryProteomics, 2009
- Use of activated graphitized carbon chips for liquid chromatography/mass spectrometric and tandem mass spectrometric analysis of tryptic glycopeptidesRapid Communications in Mass Spectrometry, 2009
- Heparan sulphate proteoglycans fine-tune mammalian physiologyNature, 2007